agilon health, inc. Investing Cash Flow
agilon health, inc. (AGL) reported Investing Cash Flow of $39.18 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-05
- agilon health, inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $19.91M, a 71.74% decline year-over-year.
- agilon health, inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $19.27M.
- agilon health, inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $22.58M, a 4.60% decline year-over-year.
- agilon health, inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $18.66M, a 59.93% decline year-over-year.
- agilon health, inc. net cash provided by (used in) investing activities for fiscal 2025 was $88.61M, a 36.66% decline from fiscal 2024.
- agilon health, inc. net cash provided by (used in) investing activities for fiscal 2024 was $139.89M.
- agilon health, inc. net cash provided by (used in) investing activities for fiscal 2023 was -$44.02M.
- agilon health, inc. net cash provided by (used in) investing activities for fiscal 2022 was -$444.39M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $19.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $39.18M 10-Q · filed 2026-08-05 | $61.77M derived: sum of 3 quarters · filed 2026-08-05 | $80.42M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $19.27M 10-Q · filed 2026-05-06 | $41.85M derived: sum of 2 quarters · filed 2026-05-06 | $60.51M derived: sum of 3 quarters · filed 2026-05-06 | $130.97M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $22.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $41.24M derived: sum of 2 quarters · filed 2026-02-25 | $111.70M derived: sum of 3 quarters · filed 2026-08-05 | $88.61M 10-K · filed 2026-02-25 |
| 2025-09-30 | $18.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $89.12M derived: sum of 2 quarters · filed 2026-08-05 | $66.03M 10-Q · filed 2025-11-04 | $89.70M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $70.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $47.37M 10-Q · filed 2026-08-05 | $71.04M derived: sum of 3 quarters · filed 2026-08-05 | $117.61M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$23.09M 10-Q · filed 2026-05-06 | $584.00K derived: sum of 2 quarters · filed 2026-05-06 | $47.15M derived: sum of 3 quarters · filed 2026-05-06 | $65.36M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $23.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $70.24M derived: sum of 2 quarters · filed 2026-02-25 | $88.45M derived: sum of 3 quarters · filed 2026-02-25 | $139.89M 10-K · filed 2026-02-25 |
| 2024-09-30 | $46.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $64.78M derived: sum of 2 quarters · filed 2025-11-04 | $116.22M 10-Q · filed 2025-11-04 | $114.02M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $18.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $69.66M 10-Q · filed 2025-08-04 | $67.45M derived: sum of 3 quarters · filed 2026-02-25 | $56.42M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $51.44M 10-Q · filed 2025-05-06 | $49.23M derived: sum of 2 quarters · filed 2026-02-25 | $38.20M derived: sum of 3 quarters · filed 2026-02-25 | $58.23M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | -$2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$13.24M derived: sum of 2 quarters · filed 2026-02-25 | $6.79M derived: sum of 3 quarters · filed 2026-02-25 | -$44.02M 10-K · filed 2026-02-25 |
| 2023-09-30 | -$11.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $9.00M derived: sum of 2 quarters · filed 2024-11-07 | -$41.82M 10-Q · filed 2024-11-07 | -$49.79M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $20.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$30.78M 10-Q · filed 2024-08-06 | -$38.75M derived: sum of 3 quarters · filed 2025-02-25 | -$169.69M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | -$50.81M 10-Q · filed 2024-05-07 | -$58.78M derived: sum of 2 quarters · filed 2025-02-25 | -$189.72M derived: sum of 3 quarters · filed 2025-02-25 | -$486.33M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | -$7.97M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$138.91M derived: sum of 2 quarters · filed 2025-02-25 | -$435.52M derived: sum of 3 quarters · filed 2025-02-25 | -$444.39M 10-K · filed 2025-02-25 |
| 2022-09-30 | -$130.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$427.55M derived: sum of 2 quarters · filed 2023-11-02 | -$436.42M 10-Q · filed 2023-11-02 | -$439.02M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | -$296.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$305.48M 10-Q · filed 2023-08-03 | -$308.08M derived: sum of 3 quarters · filed 2024-02-27 | -$319.65M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | -$8.87M 10-Q · filed 2023-05-09 | -$11.47M derived: sum of 2 quarters · filed 2024-02-27 | -$23.04M derived: sum of 3 quarters · filed 2024-02-27 | -$90.30M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | -$2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$14.17M derived: sum of 2 quarters · filed 2024-02-27 | -$81.43M derived: sum of 3 quarters · filed 2024-02-27 | -$90.51M 10-K · filed 2024-02-27 |
| 2021-09-30 | -$11.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$78.83M derived: sum of 2 quarters · filed 2022-11-03 | -$87.90M 10-Q · filed 2022-11-03 | -$64.63M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | -$67.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$76.34M 10-Q · filed 2022-08-04 | -$53.06M derived: sum of 3 quarters · filed 2023-03-01 | -$51.92M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | -$9.07M 10-Q · filed 2022-05-05 | $14.20M derived: sum of 2 quarters · filed 2023-03-01 | $15.34M derived: sum of 3 quarters · filed 2023-03-01 | $12.67M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $23.27M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $24.42M derived: sum of 2 quarters · filed 2023-03-01 | $21.75M derived: sum of 3 quarters · filed 2023-03-01 | $22.07M 10-K · filed 2023-03-01 |
| 2020-09-30 | $1.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | -$1.53M derived: sum of 2 quarters · filed 2021-10-28 | -$1.21M 10-Q · filed 2021-10-28 | |
| 2020-06-30 | -$2.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$2.35M 10-Q · filed 2021-08-04 | ||
| 2020-03-31 | $319.00K 10-Q · filed 2021-05-26 | |||
| 2019-12-31 | -$5.06M 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |